Renal actions of atrial natriuretic peptide in spontaneously hypertensive rats: The role of nitric oxide as a key mediator

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 11, 2012, Pages

  Elesgaray, Rosana ^a   Caniffi, Carolina ^a   Savignano, Lucía ^a   Romero, Mariana ^a   Laughlin, Myriam Mac ^a   Arranz, Cristina ^a   Costa, María A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Hypertension; Natriuretic peptide receptors; Nitric oxide synthase

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; CALMODULIN INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

EID: 84861884849     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00624.2011     Document Type: Article

References (36)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615, 2001.
2. Anand-Srivastava MB. Natriuretic peptide receptor-C signaling and regulation. Peptides 26: 1044-1059, 2005.
3. Costa MA, Arranz C. New aspects of the interactions between the cardiovascular nitric oxide system and natriuretic peptides. Biochem Biophys Res Commun 406: 161-164, 2011.
4. Costa MA, Elesgaray R, Balaszczuk AM, Arranz C. Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide. Regul Pept 135: 63-68, 2006.
5. Costa MA, Elesgaray R, Caniffi C, Fellet A, Arranz C. Role of cardiovascular nitric oxide system in C-type natriuretic peptide effects. Biochem Biophys Res Commun 359: 180-186, 2007.
6. Costa MA, Elesgaray R, Caniffi C, Fellet A, Mac Laughlin M, Arranz C. Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 298: H778-H786, 2010.
7. Costa MA, Elesgaray R, Loria A, Balaszczuk AM, Arranz C. Atrial natriuretic peptide influence on nitric oxide system in kidney and heart. Regul Pept 118:151-157, 2004.
8. Costa MA, Elesgaray R, Loria A, Balaszczuk AM, Arranz C. Vascular and renal effects of dopamine during extracellular volume expansion: role of nitric oxide pathway. Life Sci 78: 1543-1549, 2006.
9. Costa MA, Gonzalez Bosc LV, Majowicz MP, Vidal NA, Balaszczuk AM, Arranz CT. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 35: 1119-1123, 2000.
10. Costa MA, Loria A, Elesgaray R, Balaszczuk AM, Arranz C. Role of nitric oxide pathway in hypotensive and renal effects of furosemide during extracellular volume expansion. J Hypertens 22: 1-9, 2004.
11. Elesgaray R, Caniffi C, Rodríguez Ierase D, Visintini Jaime MF, Fellet A, Arranz C, Costa MA. Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide. Regul Pept 151: 130-134, 2008.
12. Fernández AP, Serrano J, Castro S, Salazar FJ, López JC, Nava E. Distribution of nitric oxide synthases and nitrotyrosine in the kidney of spontaneously hypertensive rats. J Hypertens 21: 2375-2388, 2003.
13. Förstermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42: 1849-1857, 1991.
14. Hong HJ, Hsiao G, Cheng TH, Yen MH. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 238: 1044-1048, 2001.
15. John SW, Veress AT, Honrath U, Chong CK, Peng L, Smithies O, Sonnenberg H. Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am J Physiol Regul Integr Comp Physiol 271: R109-R114, 1996.
16. Kagota S, Tada Y, Kubota Y, Nejime N, Yamaguchi Y, Nakamura K, Kunitomo M, Shinozuka K. Peroxynitrite is involved in the dysfunction of vasorelaxation in SHR/NDmcr-cp rats, spontaneously hypertensive rats. J Cardiovasc Pharmacol 50: 677-685, 2007.
17. Kumar U, Chen J, Sapoznikhov V, Canteros G, White BH, Sidhu A. Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rats. Clin Exp Hypertens 1: 17-31, 2005.
18. Kumar U, Shin Y, Wersinger C, Patel Y, Sidhu A. Diminished expression of constitutive nitric oxide synthase in the kidney of spontaneously hypertensive rat. Clin Exp Hypertens 25: 271-282, 2003.
19. Lee J, Kang DG, Kook H, Kim IK, Oh BS. Differentially-altered vascular guanylate cyclase isoforms in experimental hypertensive rats. J Korean Med Sci 14: 386-392, 1999.
20. Llorens S, Fernández AP, Nava E. Cardiovascular and renal alterations on the nitric oxide pathway in spontaneous hypertensive rats. Clin Hemorheol Microcirc 37: 149-156, 2007.
21. Martin ER, Lewicki JA, Scarborough RM, Ballerman BJ. Expression and regulation of ANP receptor subtypes in rat renal glomeruli and papillae. Am J Physiol Renal Fluid Electrolyte Physiol 257: F649-F657, 1989.
22. McLay JS, Chatterjee PK, Jardine AG, Hawksworth GM. Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptormediated effect. J Hypertension 13: 625-630, 1995.
23. McLay JS, Chatterjee PK, Mistry SK, Weerakoby RP, Jardine AG, McKay NG, Hawksworth GM. Atrial natriuretic factor and angiotensin II stimulate nitric oxide release from human proximal tubular cells. Clin Sci (Lond) 89: 527-531, 1995.
24. Melo Steinhelper LG, Pang SC, Tse Y, Ackermann U. ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genomics 29: 45-58, 2000.
25. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
26. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42: 271-279, 2007.
27. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides 26: 901-932, 2005.
28. Pandey KN. Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens 2: 210-226, 2008.
29. Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 57: 456-467, 2003.
30. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27: 47-72, 2006.
31. Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res 57: 813-825, 2008.
32. Tremblay J, Huot C, Willenbrock RC, Bayard F, Gossard F, Fujio N, Koch C, Kuchel O, Debinski W, Hamet P. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. J Clin Invest 92: 2499-2508, 1993.
33. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31: 1248-1254, 1998.
34. + when the Griess reaction is used to assay for nitrite. Anal Biochem 224: 502-508, 1995.
35. Woodard GE, Zhao J, Rosado JA, Brown J. A-type natriuretic peptide receptor in the spontaneously hypertensive rat kidney. Peptides 23: 1637-1647, 2002.
36. Yamamoto M, Suzuki A, Hase TJ. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. Nutr Sci Vitaminol 54: 95-98, 2008.